Literature DB >> 22843487

Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort.

Manabu Fujimoto, Takashi Matsushita, Yasuhito Hamaguchi, Kenzo Kaji, Yoshihide Asano, Fumihide Ogawa, Toshifumi Yamaoka, Keita Fujikawa, Toshiaki Tsukada, Keita Sato, Takeshi Echigo, Minoru Hasegawa, Kazuhiko Takehara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22843487     DOI： 10.1136/annrheumdis-2012-201736

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  21 in total

Review 1.  Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies.

Authors:  Lisa G Rider; James D Katz; Olcay Y Jones
Journal:  Rheum Dis Clin North Am       Date:  2013-09-19       Impact factor: 2.670

2.  Anti-MDA5-Positive Dermatomyositis Presenting as Fever of Unknown Origin.

Authors:  Lori W Lee; Neera S Narang; Anna Postolova; Nicole Seminara; Molly A Kantor
Journal:  J Gen Intern Med       Date:  2016-12       Impact factor: 5.128

3.  Antibodies to small ubiquitin-like modifier activating enzyme are associated with a diagnosis of dermatomyositis: results from an unselected cohort.

Authors:  Lisa K Peterson; Troy D Jaskowski; Sonia L La'ulu; Anne E Tebo
Journal:  Immunol Res       Date:  2018-06       Impact factor: 2.829

Review 4.  Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.

Authors:  Yoshinao Muro; Kazumitsu Sugiura; Masashi Akiyama
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

Review 5.  A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.

Authors:  Minoru Satoh; Shin Tanaka; Angela Ceribelli; S John Calise; Edward K L Chan
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

6.  Association of Dermatomyositis Sine Dermatitis With Anti-Nuclear Matrix Protein 2 Autoantibodies.

Authors:  Michio Inoue; Jantima Tanboon; Shinya Hirakawa; Hirofumi Komaki; Takeshi Fukushima; Hiroyuki Awano; Takashi Tajima; Kenji Yamazaki; Ryutaro Hayashi; Tatsuo Mori; Kazumoto Shibuya; Takahiko Yamanoi; Hajime Yoshimura; Tomohiro Ogawa; Atsushi Katayama; Fuminobu Sugai; Yoichi Nakayama; Satoko Yamaguchi; Shinichiro Hayashi; Satoru Noguchi; Hisateru Tachimori; Naoko Okiyama; Manabu Fujimoto; Ichizo Nishino
Journal:  JAMA Neurol       Date:  2020-07-01       Impact factor: 18.302

Review 7.  The Clinical Features of Myositis-Associated Autoantibodies: a Review.

Authors:  Harsha Gunawardena
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

Review 8.  Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies.

Authors:  Paige W Wolstencroft; David F Fiorentino
Journal:  Curr Rheumatol Rep       Date:  2018-04-10       Impact factor: 4.592

9.  Geographical Latitude Remains as an Important Factor for the Prevalence of Some Myositis Autoantibodies: A Systematic Review.

Authors:  Andrea Aguilar-Vazquez; Efrain Chavarria-Avila; Oscar Pizano-Martinez; Alejandra Ramos-Hernandez; Lilia Andrade-Ortega; Edy-David Rubio-Arellano; Monica Vazquez-Del Mercado
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

10.  A North American Cohort of Anti-SAE Dermatomyositis: Clinical Phenotype, Testing, and Review of Cases.

Authors:  Jemima Albayda; Christopher Mecoli; Livia Casciola-Rosen; Sonye K Danoff; Cheng Ting Lin; David Hines; Laura Gutierrez-Alamillo; Julie J Paik; Eleni Tiniakou; Andrew L Mammen; Lisa Christopher-Stine
Journal:  ACR Open Rheumatol       Date:  2021-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.